Last reviewed · How we verify
NCT06730984
Endoscopy-Assisted Tracheal Intubation Versus Conventional Tracheal Intubation for Endoscopic Submucosal Dissection (ESD): a Prospective Randomized Controlled Study
NA trial testing Endoscopy-Assisted Tracheal Intubation in Tracheal Intubation in 132 participants. Not yet recruiting.
8 December 2026
Quick facts
| Lead sponsor | Ningbo No. 1 Hospital |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 132 |
| Start date | 10 December 2024 |
| Primary completion | 8 December 2026 |
| Estimated completion | 10 December 2026 |
| Sites | 1 location across China |
Drugs / interventions tested
- Endoscopy-Assisted Tracheal Intubation
- Traditional Tracheal Intubation
Conditions studied
- Tracheal Intubation — all drugs for Tracheal Intubation →
- Endoscopic Submucosal Dissection — all drugs for Endoscopic Submucosal Dissection →
- Endoscopy-Assisted — all drugs for Endoscopy-Assisted →
- Video Laryngoscope — all drugs for Video Laryngoscope →
Sponsor
Ningbo No. 1 Hospital
Who can join
Adults 18 to 75, any sex, with Tracheal Intubation or Endoscopic Submucosal Dissection. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study plans to enroll 148 patients undergoing upper gastrointestinal endoscopic submucosal dissection (ESD). Patients will be randomly divided into a control group (conventional tracheal intubation) and an experimental group (endoscopy-assisted tracheal intubation). Patients meeting the inclusion criteria and not falling under the exclusion criteria will be invited to participate in the study. Upon providing voluntary consent, the research physician will arrange for the patient's inclusion in the study. After signing the informed consent form, the research physician will collect the patient's basic information, medical history, and other details, followed by timing the preoperative preparation period and evaluating postoperative discomfort
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06730984
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Tracheal Intubation
Currently open trials in the same condition.
- NCT06564857 — Remifentanil Versus Rocuronium for Optimizing Video Laryngoscopy-assisted Tracheal Intubation · Phase 4 · recruiting
- NCT06660784 — Mechanism of Nitric Oxide on Ventilator-induced Diaphragm Dysfunction with Extracorporeal Membrane Lung Assistance · active not recruiting
- NCT06514690 — Postoperative Memories and Level of Sedation for Tracheal Intubation Using Fiberoptic Bronchoscopy/Videolaryngoscopy · recruiting
- NCT02514655 — Simple Mechanical Device to Control Pressure in the Balloon of the Endotracheal Tube to Prevent Ventilator-acquired Pneu · NA · recruiting
Other Ningbo No. 1 Hospital trials
Trials by the same sponsor.
- NCT07181759 — Clinical Trial of VISOR vs fURS for Upper Urinary Tract Stone · NA · not yet recruiting
- NCT07001865 — Metabolically Healthy Obesity Increases the Risks of MASLD and Hyperuricemia · enrolling by invitation
- NCT06984510 — Accelerated Biological Aging is Associated With Increased Risk of T2DM in the MASLD Population · recruiting
- NCT06905795 — Screening and Intervention of MASLD in Children · NA · active not recruiting
- NCT06987760 — Comparing Different Diameter fURSs With Similar RESDs for the Treatment of Upper Urinary Tract Stones · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06730984 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ningbo No. 1 Hospital
- Last refreshed: 12 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06730984.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing